Michael J. Astrue, general counsel of the U.S. Department ofHealth and Human Services, has joined the Boston law firmMintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. and itshealth services group. Astrue will also serve as a managingdirector of Mintz Levin's strategic consulting affiliate, MLStrategies Inc. Astrue submitted his resignation as generalcounsel of HHS in June.

Selectide Corp. of Tucson, Ariz., name Bruce E. Seligmann vicepresident of research. Seligmann was a senior research fellowin the Department of Inflammation/Osteoarthritis, MolecularBiology and Enzymology Research at Ciba-Geigy Corp.

Cynthia T. Healy was named director of life science research atthe venture capital firm of Kleiner Perkins Caufield & Byers inPalo Alto, Calif. She previously workde for Ciba-Geigy Corp. andHoffmann LaRoche.

Edwin C. Cadman of Yale University School of Medicine wasnamed to the board of directors of CytoTherapeutics Inc. ofProvidence, R.I.

Idexx Laboratories Inc. of Westbrook, Maine, elected KennethPaigen, director of the Jackson Laboratory, to its board ofdirectors.

Phytopharmaceuticals Inc. of San Carlos, Calif., a subsidiary ofEscagenetics Inc., named Peter J. Hylands vice president andchief scientist. Hylands was director of natural productschemistry at Xenova Ltd. of Berkshire, England. Marian InesChicarelli-Robinson is replacing Hyland as head of Xenova'snatural products chemistry division.

Embrex Inc. of Research Triangle Park, N.C., named DavidBaines director of European operations. Baines was managingdirector of Rhone Merieux Ltd, a subsidiary of Rhone-Poulenc.

(c) 1997 American Health Consultants. All rights reserved.